The NTIS website and supporting ordering systems are undergoing a major upgrade from 8PM on September 25th through approximately October 6. During that time, much of the functionality, including subscription and product ordering, shipping, etc., will not be available. You may call NTIS at 1-800-553-6847 or (703) 605-6000 to place an order but you should expect delayed shipment. Please do NOT include credit card numbers in any email you might send NTIS.
Documents in the NTIS Technical Reports collection are the results of federally funded research. They are directly submitted to or collected by NTIS from Federal agencies for permanent accessibility to industry, academia and the public.  Before purchasing from NTIS, you may want to check for free access from (1) the issuing organization's website; (2) the U.S. Government Printing Office's Federal Digital System website; (3) the federal government Internet portal; or (4) a web search conducted using a commercial search engine such as
Accession Number ADA564468
Title Purinergic Receptors in Quiescence and Localization of Leukemic Stem Cells.
Publication Date May 2012
Media Count 19p
Personal Author B. Lee
Abstract How leukemia stem cells gained resistance to radiation and chemotheraphy is poorly defined, yet critically determines how leukemia cells tolerate conventional leukemia therapy. Normal hematopoietic stem cells and leukemia initiating cells are known to share many functional properties. Therefore, they are supposed to utilize many common mechanistic pathways for their survival and migration. Using genetically engineered mice we demonstrated the functional roles of P2Y14 in preserving regenerative capacity by constraining senescence induction and molecular events governing it. Since P2Y14 is highly expressed in differentiation-resistant leukemia cells, P2Y14 expression in leukemia cells may also function in modulating the resistance to conventional cancer treatment. We believe these data define for the first time in mammals the identity and impact of a receptor modulating stem/progenitor tolerance of stress. By providing a mechanistic insight for the roles of P2Y14 in the stress-induced injury, our preliminary results are expected to provide the foundation for an effective treatment to destroy therapy resistant leukemia cells. In addition, we identified a nucleotide sugar, UDP-Glc, as a novel mobilizer of long-term repopulating HSPCs. This finding may also have important clinical implications in designing new mobilization strategies to improve the efficiency and outcome of autologous and allogeneic peripheral blood stem cell (PBSC) transplantation.
Keywords Aging(Physiology)
Blood cells
Cellular senescence
Clinical medicine
Hematopoietic cells
Leukemic stem cell
Purinergic receptor
Stem cells

Source Agency Non Paid ADAS
NTIS Subject Category 57E - Clinical Medicine
Corporate Author Pittsburgh Univ., PA.
Document Type Technical report
Title Note Annual rept. 1 May 2011-30 Apr 2012.
NTIS Issue Number 1303
Contract Number W81XWH09-1-0364

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader